Viewing StudyNCT00455013



Ignite Creation Date: 2024-05-05 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00455013
Status: COMPLETED
Last Update Posted: 2014-06-09
First Post: 2007-03-30

Brief Title: A Phase II Study of Belatacept BMS-224818 With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-07
Start Date Type: None
Primary Completion Date: 2008-10
Primary Completion Date Type: ACTUAL
Completion Date: 2012-08
Completion Date Type: ACTUAL
First Submit Date: 2007-03-30
First Submit QC Date: March 30 2007
Study First Post Date: 2007-04-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2013-11-21
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2010-04-29
Disp First Submit QC Date: April 29 2010
Disp First Post Date: 2010-05-03
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2014-05-27
Last Update Post Date: 2014-06-09
Last Update Post Date Type: ESTIMATED